Results 241 to 250 of about 194,506 (328)

Effects of nortriptyline and paroxetine on QT variability in patients with panic disorder

, 2000
Vikram K. Yeragani, R. O. Pohl, V.C. Jampala, Richard Balon, Chilakamarri Ramesh, K. Srinivasan   +5 more
openalex   +1 more source

Can enhanced street lighting improve public safety at scale?

Criminology &Public Policy, EarlyView.
Abstract Research Summary Street crimes are thought to be influenced by changes in ambient lighting; yet, most studies have focused on small‐scale interventions in limited areas. It remains unclear whether enhanced lighting can improve safety on a larger, jurisdiction‐wide scale.
John M. MacDonald, Aaron Chalfin, Maya Moritz, Brian Wade, Alyssa K. Mendlein, Anthony A. Braga, Eugenia South   +6 more
wiley   +1 more source

Acute effects of 150 mg caffeine on subjective, physiological, and behavioral components of anxiety in panic disorder and healthy controls - A randomized placebo-controlled crossover trial. [PDF]

J Psychopharmacol
Hoppe JM, Björkstrand J, Vegelius J, Klevebrant L, Gingnell M, Frick A.   +5 more
europepmc   +1 more source

Psychological Comorbidity in Patients Presenting to the Emergency Department With Low‐Risk Chest Pain and Anxiety

Academic Emergency Medicine, EarlyView.
ABSTRACT Objective Low‐risk chest pain (LRCP) is one of the most common conditions presenting in the emergency department (ED) and is strongly associated with anxiety. The purpose of this study is to determine the prevalence of other psychological comorbidities and clinical factors associated with severe anxiety in LRCP.
Linh Dang, Kurt Kroenke, Jill Connors, Timothy E. Stump, Patrick O. Monahan, Yelena Chernyak, Emily Holmes, Colin Hoffman, Kevin Prather, Paul I. Musey   +9 more
wiley   +1 more source

Sartre, Existentialism and Panic Attacks [PDF]

, 1992
du Plessis, Eric H.
core   +1 more source

Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial

Addiction, EarlyView.
Abstract Background and Aims Psilocybin has emerged as a potential treatment for alcohol use disorder (AUD), but early efficacy data are inconsistent. Depression following alcohol detoxification significantly increases the risk of relapse. This pilot study aimed to evaluate the feasibility, acceptability, and preliminary efficacy of psilocybin‐assisted
Amandine Luquiens, Dahbia Belahda, Carine Graux, Noe Igounenc, Chris Serrand, Paul Rochefort, Thibault Mura, Felix Sergent   +7 more
wiley   +1 more source

Integrating Heart Rate Variability Improves Machine Learning-based Prediction of Panic Disorder Symptom Severity. [PDF]

Clin Psychopharmacol Neurosci
Lee JG, Kim JJ, Seok JH, Kim E, Oh J, Bang CB, Kim BH.   +6 more
europepmc   +1 more source

The relationship between 3,4‐methylenedioxymethamphetamine (MDMA) use in young adulthood and anxiety or depressive disorders in the mid‐30s: Findings from the Victorian Adolescent Health Cohort Study

Addiction, EarlyView.
Abstract Background and aims MDMA (3,4‐methylenedioxymethamphetamine or “Ecstasy”) is the fourth‐most used illicit substance globally. While previous research found links between MDMA use and mental health outcomes, the direction and nature of this relationship remain unclear.
Zachary Bryant, Kirsten Morley, Jessica A. Kerr, Craig A. Olsson, Tim Slade   +4 more
wiley   +1 more source